https://www.selleckchem.com/pr....oducts/oprozomib-onx
001). Of the 41 Phase 2 students (100% response rate), after the lab exercise, all felt that firsthand experience enhanced classroom instruction and increased confidence and preparedness when administering N O to a patient (all P.001). Fifty-six (71%) Phase 1 and 39 (80%) Phase 2 students believed classroom instruction alone was inadequate to prepare them to administer N O/O (both P.001). Our results strongly suggest that experiential learning of N O/O inhalation sedation through a hands-on laboratory exercise should
Like
Comment
Share
